Legal & General Group’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$91.5K Sell
2,396
-157
-6% -$4.97K ﹤0.01% 2613
2025
Q4
$55.7K Sell
2,553
-46
-2% -$955 ﹤0.01% 2710
2025
Q3
$55.8K Sell
2,599
-8,704
-77% -$195K ﹤0.01% 2709
2025
Q2
$290K Buy
11,303
+1,857
+20% +$54.3K ﹤0.01% 2567
2025
Q1
$346K Hold
9,446
﹤0.01% 2513
2024
Q4
$290K Sell
9,446
-2,921
-24% -$97.1K ﹤0.01% 2612
2024
Q3
$466K Sell
12,367
-301
-2% -$11.6K ﹤0.01% 2488
2024
Q2
$502K Sell
12,668
-934
-7% -$30.2K ﹤0.01% 2420
2024
Q1
$457K Buy
13,602
+365
+3% +$12.3K ﹤0.01% 2464
2023
Q4
$441K Buy
13,237
+2,315
+21% +$74.7K ﹤0.01% 2505
2023
Q3
$343K Sell
10,922
-448
-4% -$14.1K ﹤0.01% 2582
2023
Q2
$360K Buy
11,370
+5,383
+90% +$174K ﹤0.01% 2568
2023
Q1
$198K Buy
5,987
+489
+9% +$16K ﹤0.01% 2595
2022
Q4
$177K Hold
5,498
﹤0.01% 2658
2022
Q3
$197K Buy
5,498
+1,044
+23% +$43.3K ﹤0.01% 2632
2022
Q2
$183K Buy
4,454
+292
+7% +$14.2K ﹤0.01% 2665
2022
Q1
$241K Buy
4,162
+144
+4% +$7.88K ﹤0.01% 2607
2021
Q4
$236K Hold
4,018
﹤0.01% 2655
2021
Q3
$244K Buy
4,018
+2,302
+134% +$135K ﹤0.01% 2622
2021
Q2
$103K Sell
1,716
-253
-13% -$12.7K ﹤0.01% 2722
2021
Q1
$93K Buy
1,969
+161
+9% +$6.63K ﹤0.01% 2642
2020
Q4
$68K Hold
1,808
﹤0.01% 2705
2020
Q3
$59K Sell
1,808
-900
-33% -$38.1K ﹤0.01% 2633
2020
Q2
$122K Buy
2,708
+470
+21% +$24K ﹤0.01% 2478
2020
Q1
$98K Sell
2,238
-499
-18% -$22.6K ﹤0.01% 2418
2019
Q4
$118K Buy
2,737
+419
+18% +$17.1K ﹤0.01% 2546
2019
Q3
$84K Buy
2,318
+300
+15% +$12.6K ﹤0.01% 2573
2019
Q2
$95K Hold
2,018
﹤0.01% 2551
2019
Q1
$71K Buy
2,018
+133
+7% +$5.23K ﹤0.01% 2606
2018
Q4
$70K Buy
1,885
+588
+45% +$23K ﹤0.01% 2569
2018
Q3
$44K Hold
1,297
﹤0.01% 2833
2018
Q2
$32K Sell
1,297
-286
-18% -$7.97K ﹤0.01% 2983
2018
Q1
$47K Sell
1,583
-647
-29% -$21.7K ﹤0.01% 2774
2017
Q4
$72K Sell
2,230
-820
-27% -$26.4K ﹤0.01% 2730
2017
Q3
$92K Buy
3,050
+454
+17% +$12.4K ﹤0.01% 2691
2017
Q2
$61K Hold
2,596
﹤0.01% 2849
2017
Q1
$58K Sell
2,596
-95
-4% -$2.15K ﹤0.01% 2823
2016
Q4
$62K Buy
2,691
+843
+46% +$20.3K ﹤0.01% 2813
2016
Q3
$43K Hold
1,848
﹤0.01% 2591
2016
Q2
$39K Buy
1,848
+846
+84% +$26.6K ﹤0.01% 2594
2016
Q1
$34K Hold
1,002
﹤0.01% 2558
2015
Q4
$29K Hold
1,002
﹤0.01% 2647
2015
Q3
$29K Buy
+1,002
New +$32.8K ﹤0.01% 2650

Other funds holding ATEX

Legal & General Group's ATEX Position: Q1 2026 in Review

Legal & General Group reduced its Anterix (ATEX) stake by 6.1% in Q1 2026, selling an estimated $4.97K and leaving 2,396 shares worth $91.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2613.

Legal & General Group first reported a position in ATEX in Q3 2015 and has held it in 43 quarters since. The position peaked at $502K in Q2 2024. 132 funds tracked by Wall St. Rank hold ATEX as of Q1 2026.

  • Legal & General Group held 2,396 shares of Anterix worth $91.5K as of Q1 2026.
  • Legal & General Group sold 157 Anterix shares in Q1 2026, an estimated $4.97K.
  • Anterix made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #2613 holding.
  • Legal & General Group first reported a position in Anterix in Q3 2015 and has held it in 43 quarters since.
  • Legal & General Group's Anterix position peaked at $502K in Q2 2024.
  • 132 funds tracked by Wall St. Rank held Anterix as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.